Compliance Monitoring and Testing

Compliance monitoring and testing are the operational mechanisms through which organizations verify that their internal controls, policies, and procedures are functioning as designed and producing regulatory adherence in practice. This page covers the definition and scope of these activities, how structured monitoring and testing programs operate, the scenarios in which each method applies, and the decision boundaries that determine which approach a compliance function should deploy. Understanding this discipline is foundational to building a defensible compliance program and to satisfying audit expectations set by federal regulators.

Definition and scope

Compliance monitoring refers to the ongoing, routine observation and measurement of activities, controls, and outcomes to confirm that operations remain within established regulatory and policy boundaries. Compliance testing refers to discrete, structured evaluations—often transactional, sample-based, or cyclical—designed to produce a pass/fail or risk-rated assessment of specific controls or processes.

The distinction is not merely semantic. Monitoring is continuous or near-continuous; testing is episodic. The U.S. Department of Justice (DOJ) Criminal Division's Evaluation of Corporate Compliance Programs guidance (updated June 2020) draws this line explicitly, asking whether a compliance program includes "a mechanism to detect and address compliance weaknesses" through ongoing monitoring versus periodic testing of controls. Organizations subject to the Federal Sentencing Guidelines for Organizations (USSG §8B2.1) are expected to demonstrate both.

Scope of coverage extends across financial controls, data privacy requirements, workplace safety protocols, anti-corruption obligations, and sector-specific rules. The scope of a compliance program determines which regulatory domains require monitoring and testing coverage and at what frequency.

How it works

A functional monitoring and testing program operates through structured phases rather than ad hoc review. The following breakdown reflects the architecture described in frameworks such as NIST SP 800-53 (Control CA-7, Continuous Monitoring) and the COSO Internal Control–Integrated Framework published by the Committee of Sponsoring Organizations of the Treadway Commission.

1. Planning and risk stratification — The compliance function identifies the universe of controls, maps each control to a specific regulatory obligation, and assigns risk ratings. Higher-risk controls receive higher-frequency monitoring or more intensive testing cycles.
2. Control identification and documentation — Each control is documented with its owner, objective, testing procedure, and acceptable evidence. This feeds directly into compliance documentation requirements.
3. Monitoring execution — Automated or manual procedures track control operation in real time or at defined intervals. Examples include exception reporting on transaction systems, dashboard alerts on access controls, and automated policy attestation tracking.
4. Testing execution — Testers select samples from a defined population (transactions, records, system configurations), apply a test procedure, and evaluate results against a predetermined standard. Sample sizes are determined by risk level and population size, often guided by statistical sampling standards referenced in the AICPA's audit and attestation standards.
5. Results analysis and escalation — Deficiencies identified through monitoring triggers or failed tests are classified by severity, routed to control owners, and escalated per the organization's compliance violation remediation procedures.
6. Reporting and trend analysis — Results are aggregated into compliance reports reviewed by leadership and, where required, by regulators or audit committees. Trending data identifies systemic weaknesses versus isolated failures.
7. Program adjustment — Findings feed back into the risk assessment cycle, adjusting monitoring frequency or testing depth for controls that show persistent weakness.

Common scenarios

Financial services regulatory compliance — Banks subject to the Bank Secrecy Act (BSA) and FinCEN regulations are required to maintain Anti-Money Laundering (AML) programs that include independent testing (31 U.S.C. § 5318(h)). Transaction monitoring systems flag suspicious activity patterns; periodic testing evaluates whether the flagging logic is calibrated correctly and whether Suspicious Activity Reports (SARs) are filed within the 30-day statutory window.

Healthcare HIPAA compliance — The HHS Office for Civil Rights (OCR) expects covered entities to conduct periodic technical and nontechnical evaluations of safeguards per 45 CFR § 164.308(a)(8). Monitoring covers access logs and audit controls; testing evaluates whether access rights are provisioned correctly and whether breach notification policies operate as written.

Workplace safety — OSHA's 29 CFR Part 1904 recordkeeping requirements call for ongoing monitoring of injury and illness logs. Organizations in high-hazard industries conduct periodic safety audits that function as structured compliance tests of physical controls, training records, and equipment maintenance logs.

Anti-corruption and FCPA programs — The DOJ/SEC FCPA Resource Guide (2nd ed., 2020) describes third-party due diligence monitoring as a core expectation. Testing in this context examines whether gift, travel, and entertainment approvals are documented and within policy thresholds.

Decision boundaries

The choice between monitoring and testing—or the calibration of each—hinges on four primary factors:

Risk level of the underlying obligation. Controls governing high-penalty regulatory requirements (such as HIPAA civil monetary penalties, which can reach $1.9 million per violation category per year per HHS CMPs) warrant continuous monitoring rather than annual testing alone.

Control stability. A newly implemented control with no performance history should be tested immediately and retested at short intervals. A control with a documented history of consistent performance may shift to monitoring-only with less frequent formal testing.

Regulatory mandate specificity. Where a regulation explicitly requires independent testing (as in BSA/AML), testing cannot be substituted by monitoring. Where regulations require "reasonable safeguards" without prescribing method, the compliance function has discretion to weight monitoring versus testing based on the compliance risk assessment.

Resource and materiality thresholds. Organizations use materiality thresholds to determine minimum sample sizes and testing depth. Smaller organizations operating under the compliance by business size considerations in federal sentencing guidance may apply risk-based sampling rather than full-population testing, provided the rationale is documented.

Monitoring and testing are not interchangeable, and substituting one for the other without documented justification creates a gap that regulators—including the DOJ, OCR, and OSHA—treat as evidence of program inadequacy.

References

• U.S. Department of Justice, Evaluation of Corporate Compliance Programs (June 2020)
• U.S. Sentencing Commission, Guidelines Manual §8B2.1 (2023)
• NIST SP 800-53 Rev. 5, Control CA-7: Continuous Monitoring
• HHS Office for Civil Rights, HIPAA Security Rule 45 CFR § 164.308(a)(8)
• HHS Civil Monetary Penalties, HIPAA Enforcement
• OSHA Recordkeeping Rule, 29 CFR Part 1904
• DOJ/SEC FCPA Resource Guide, 2nd Edition (2020)
• FinCEN, Bank Secrecy Act Requirements, 31 U.S.C. § 5318(h)
• COSO Internal Control–Integrated Framework, Committee of Sponsoring Organizations of the Treadway Commission